Literature DB >> 10370669

Combined therapy with radiofrequency thermal ablation and intra-arterial infusion chemotherapy for hepatic metastases from colorectal cancer.

O Kainuma1, T Asano, H Aoyama, W Takayama, T Nakagohri, T Kenmochi, M Hasegawa, Y Tokoro, S Sasagawa, T Ochiai.   

Abstract

BACKGROUND/AIMS: In this preliminary study, we investigated the efficacy of combined radiofrequency thermal ablation therapy (RFA) with hepatic arterial infusion chemotherapy (HAI) in the treatment of multiple liver metastases from colorectal cancer.
METHODOLOGY: Nine patients with bilobular multiple metastases was treated. The number of nodules was 6.0 +/- 3.9 (range: 2-13), and the size was 2.1 +/- 1.0 cm (range: 0.5-4.8 cm) in diameter. RFA was performed using a RF generator operating at 460 kHz with a 15-gauge, 4-prong custom RF needle. Treatment temperature was kept at 90-110 degrees C for 5 min. 5-Fluorouracil (5-FU) was administered by weekly 750-1250 mg/body/5 h as the regimen of HAI.
RESULTS: During a 15.2-month follow-up period, 6 of 9 patients survived more than 1 year. Three of the 6 survived more than 2 years. Serum CEA level in 5 patients dropped from 24.5 +/- 9.5 ng/ml to 10.3 +/- 5.5 ng/ml. Local recurrence was observed in 5 patients and new lesions in 4. Extrahepatic recurrence was observed in 5 patients. There were no serious complications but one HAI-related cerebral thrombosis.
CONCLUSIONS: Combined RFA with HAI would be effective and safe. This modality provides a new option for the treatment of multiple liver metastases from colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10370669

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  10 in total

Review 1.  Ablative therapy for liver tumours.

Authors:  E A Dick; S D Taylor-Robinson; H C Thomas; W M W Gedroyc
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

2.  The treatment of primary and metastatic hepatic neoplasms using percutaneous cryotherapy.

Authors:  Mitchell T Smith; Charles E Ray
Journal:  Semin Intervent Radiol       Date:  2006-03       Impact factor: 1.513

3.  Ultrasound-guided radiofrequency thermal ablation of liver tumors: percutaneous, laparoscopic, and open surgical approaches.

Authors:  J Machi; S Uchida; K Sumida; W M Limm; S A Hundahl; A J Oishi; N L Furumoto; R H Oishi
Journal:  J Gastrointest Surg       Date:  2001 Sep-Oct       Impact factor: 3.452

4.  Short- and-long term results of intraoperative radiofrequency ablation of liver metastases.

Authors:  G Navarra; A Ayav; J-C Weber; S L Jensen; C Smadga; J P Nicholls; N A Habib; L R Jiao
Journal:  Int J Colorectal Dis       Date:  2005-04-28       Impact factor: 2.571

Review 5.  Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan; Flora Hau-Fung Tsang; John Wong
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

6.  Percutaneous radiofrequency thermal ablation with hypertonic saline injection: in vivo study in a rabbit liver model.

Authors:  Jeong Min Lee; Young Kon Kim; Young Hwan Lee; Sang Won Kim; Chun Ai Li; Chong Soo Kim
Journal:  Korean J Radiol       Date:  2003 Jan-Mar       Impact factor: 3.500

7.  Role of contrast enhanced ultrasound in radiofrequency ablation of metastatic liver carcinoma.

Authors:  Jin-Yu Wu; Min-Hua Chen; Wei Yang; Shu-Zhi Lin; Wei Wu; Shan-Shan Yin; Hui Zhang; Kun Yan
Journal:  Chin J Cancer Res       Date:  2012-03       Impact factor: 5.087

8.  Combined radiofrequency ablation and acetic acid hypertonic saline solution instillation: an in vivo study of rabbit liver.

Authors:  Jeong Min Lee; Young Kon Kim; Sang Won Kim; Joon Koo Han; Se Hyung Kim; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2004 Jan-Mar       Impact factor: 3.500

Review 9.  Actual role of radiofrequency ablation of liver metastases.

Authors:  Philippe L Pereira
Journal:  Eur Radiol       Date:  2007-02-15       Impact factor: 7.034

Review 10.  [Combined therapies including interventional radiology].

Authors:  S Clasen; P L Pereira
Journal:  Radiologe       Date:  2007-12       Impact factor: 0.803

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.